Short answer

False-positive STI results cluster where imperfect tests meet low-risk populations. Herpes blood tests in asymptomatic people above all, syphilis non-treponemal screens from cross-reacting conditions, rare HIV screening reactions, and uncommon NAAT contamination or dead-DNA cases.

Confirmation algorithms exist precisely to intercept these before they become misdiagnoses with real-life consequences: never act on a single unexpected positive alone. Confirm first, disclose and treat after.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Which tests false-positive. Ranked by frequency

  • Herpes type-specific IgG in asymptomatic low-risk testers: notorious. Low-positive index values false-positive often enough that confirmation is standard practice.
  • Syphilis non-treponemal screens (RPR/VDRL): biologic false positives from pregnancy, autoimmune disease, other infections, and age. Treponemal tiebreakers sort them.
  • HIV screens: rare, and always reflex-confirmed by differentiation cascades before anyone is told “positive.” NAAT for chlamydia/gonorrhea: rare contamination, sample mix-ups, and dead-DNA detection post-treatment (treated infections staying NAAT-positive for weeks).

Unexpected positives in any category get clinical review and, where indicated, repeat testing before partner-confrontation decisions.

The mirror problem, missed infections, lives at False-Negative STI Tests: Why They Happen.

The prevalence math. Why screening context decides meaning

Even a 99%-specific test yields mostly-false positives when screening populations with under 1% prevalence: out of 1,000 low-risk people tested, ~10 false positives swamp the few true ones.

This Bayes-theorem reality is why routine herpes blood screening is discouraged (low prevalence plus imperfect specificity equals misleading results) and why every screening positive needs confirmation.

Positive predictive value, the chance a positive is true, depends on pre-test probability more than on test quality.

Clinicians estimate pre-test probability from your history; the same result means different things in different patients.

Confirmation pathways. Standardized, ask by name

  • Herpes: repeat with an alternate assay or Western-blot pathway (low-positive indices specifically. Confirm before accepting).
  • Syphilis: treponemal tiebreakers plus clinical staging (history, examination, prior treatment records).
  • HIV: differentiation immunoassay cascade with RNA where indicated (staged results over days. Each stage narrowing).
  • NAAT surprises: clinical review plus retest (fresh sample, verified collection, exposure-history reconciliation).

Each pathway is standardized. Asking “what is the confirmatory pathway for this result?” moves care forward immediately.

While resolving. Discipline protecting everyone

  • Abstain pending clarity (precaution without verdict).
  • Avoid disclosing unconfirmed results as final (“my screening test was reactive and I’m getting confirmatory testing”. Accurate, non-alarming).
  • Document the testing sequence (dates, assays, index values, laboratories. Confirmation runs smoother with records).
  • Let clinicians, not forums, interpret tiebreakers (index-value nuances and cascade logic need professional reading).

When to seek care

Immediately for confirmatory testing of any surprising positive, before disclosing or treating on a single result, and for retesting schedules that settle the question.